Difference between revisions of "CT Volumetry Biomarker Ctte"

From QIBA Wiki
Jump to navigation Jump to search
 
(74 intermediate revisions by 4 users not shown)
Line 1: Line 1:
 
{{TOCright}}
 
{{TOCright}}
:Co-chairs: Gregory Goldmacher, MD, PhD, MBA; Jenifer Siegelman, MD, MPH; Ehsan Samei, PhD
+
:Co-chairs: Rudresh Jarecha, MBBS, DNB, DMRE; Ehsan Samei, PhD and TBD
:Secretary: Julie Lisiecki
+
:RSNA Staff Support: Julie Lisiecki
 
* [http://tinyurl.com/QIBA-CT-Vol-Roster Roster]
 
* [http://tinyurl.com/QIBA-CT-Vol-Roster Roster]
 +
* [https://docs.google.com/spreadsheets/d/1qbBHaJNTAqHnAcmCTHsNfDph7hMyJ3NoUjYSdilVw8w/edit#gid=267283460 Attendance & Voting Privileges]
  
 
==Meetings==
 
==Meetings==
* Tcons are held roughly Weekly. Contact the secretary for details.
+
* Tcons are held periodically. Contact RSNA Staff for details.
* [[Call Summaries]]
 
*[[Media:10 16 2017 QIBA CT Volumetry BC Call-FINAL.pdf|10.16.2017 QIBA CT Volumetry Call Summary]]
 
*[[Media:10 02 2017 QIBA CT Volumetry BC Call-FINAL.pdf|10.02.2017 QIBA CT Volumetry Call Summary]]
 
*[[Media:09 11 2017 QIBA CT Volumetry BC Call-FINAL2.pdf|09.11.2017 QIBA CT Volumetry Call Summary]]
 
*[[Media:08 28 2017 QIBA CT Volumetry BC Call-FINAL2.pdf|08.28.2017 QIBA CT Volumetry Call Summary]]
 
*[[Media:08 07 2017 QIBA CT Volumetry BC Call-FINAL2.pdf|08.07.2017 QIBA CT Volumetry Call Summary]]
 
*[[Media:07 17 2017 QIBA CT Volumetry BC Call-FINAL.pdf|07.17.2017 QIBA CT Volumetry Call Summary]]
 
''
 
'''[[Call Summaries Archive]]'''''
 
  
==Profile Development==
 
  
===Advanced Disease/Tumor Volume Change Profile===
+
'''Recent Call Summaries:'''
 +
*[[Media:11 01 2022 QIBA CT Volumetry BC Call-FINAL.pdf|11.01.2022 QIBA CT Volumetry BC Call Summary]]
 +
*[[Media:10 10 2022 QIBA CT Volumetry BC Call-FINAL.pdf|10.10.2022 QIBA CT Volumetry BC Call Summary]]
 +
*[[Media:08 17 2022 QIBA CT Volumetry BC Call-FINAL.pdf|08.17.2022 QIBA CT Volumetry BC Call Summary]]
 +
*[[Media:06 29 2022 QIBA CT Volumetry BC Call-FINAL.pdf|06.29.2022 QIBA CT Volumetry BC Call Summary]]
 +
*[[Media:05 26 2022 QIBA CT Volumetry BC Call-FINAL.pdf|05.26.2022 QIBA CT Volumetry BC Call Summary]]
 +
*[[Media:04 20 2022 QIBA CT Volumetry BC Call-FINAL.pdf|04.20.2022 QIBA CT Volumetry BC Call Summary]]
 +
*[[Media:03 15 2022 QIBA CT Volumetry BC Call-FINAL.pdf|03.15.2022 QIBA CT Volumetry BC Call Summary]]
 +
*[[Media:02 15 2022 QIBA CT Volumetry BC Call-FINAL.pdf|02.15.2022 QIBA CT Volumetry BC Call Summary]]
  
'''Status - Consensus Profile complete'''
 
*[[Media:QIBA_CTVol_TumorVolumeChangeProfile_Consensus-20161121b.pdf | QIBA Profile: CT Tumor Volume Change Profile]] ''CONSENSUS 2016.11.21b''
 
:* [[Media:QIBA_CVol_TumorVolumeChangeChecklist-20161205_-_Field_Test_version_1.0.docx| Checklist - CT Tumor Volumetry for Advanced Disease]] ''Field Trial v1.0''
 
  
'''Status - Technical Confirmation in progress'''
+
'''''[[CT Volumetry BC Call Summaries Archive]]'''''
*[[Media:QIBA_CTVol_TumorVolumeChangeProfile_PostConsensus-20170403.docx | CT Tumor Volume Change Profile - PostConsensus]] ''DRAFT 2017.04.03''
 
* '''[https://docs.google.com/spreadsheets/d/1cyz0frvELb6Tq1EHjpHxnvjeUxotExnJ3OrKPdIa30U/edit?usp=sharing Technical Confirmation Results and Resolutions]''' - ONGOING WORK
 
:* Columbia Volume repeatability assessment - Coming Soon
 
::* [[Media:QIBA_CT_Volumetry_Field_Test_ACR_Phantom_Scan_Protocol.pdf| Columbia Scan Protocol]]
 
  
Past and Future
+
==Profile Development==
:* [[Archived Versions#Advanced_disease|Archived Versions]] of Profile-related documents.
+
'''Streamlined Profile (also on Profile page)'''
:* [[CTV-AD Considerations for Future Editions|Considerations for Future Editions of CTV-AD]]
+
* [[Media:QIBACTVol_TumorVolumeChange(2022)-20220721.pdf|CT Tumor Volume Change for Advanced Disease (CTV-AD) 2022-07-21 Streamlined Profile]]
 +
:* 32 pages including Conformance Checklists
  
  
 +
'''Status - Balloting Streamlined Profile'''
 +
*[[Media:QIBA Profile Streamlining Proposal - CTVol TumorVolumeChange-20220303.docx| CT Tumor Volume Change Profile - Streamlined]] Draft 2022.03.03
 +
*[[Media:QIBA Profile Streamlining Proposal - CTVol TumorVolumeChange-20211209.docx| CT Tumor Volume Change Profile - Streamlined]] Draft 2021.12.09
  
===<font color=green>Lung Nodule Assessment in CT Screening Profile</font>===
+
The Technically Confirmed Profile is on the [[Profiles]] page.
  
=====<font color=red>Status - ''Final Review in progress''</font>=====
+
'''Stage 4 Planning'''
 +
:* [https://docs.google.com/document/d/1Wcmkzp8N_2lLL-FCykNPwgsn1BJOs7Z9A1ZyTIkuGCo/edit?usp=sharing Draft Stage 4 Plan - Google Doc]
  
* [[Media:2017-10-07 Final QIBASmallNoduleProfileTF CommentResponse.pdf|QIBA Lung Nodule Profile Comment Response]] ''2017.10.07''
+
'''Past and Future'''
* [[Media:QIBA_CT_Vol_LungNoduleAssessmentInCTScreening_2017.09.27.docx|QIBA Lung Nodule Profile]] ''Draft 2017.09.27''
+
:* [[Archived Versions#Advanced_disease|Archived Versions]] of Profile-related documents.
 
+
:* [[CTV-AD Considerations for Future Editions|Considerations for Future Editions of CTV-AD]]
=====<font color=red>'''''Supporting documents:'''''</font>=====
 
 
 
* [[Media:Ref3_SPIE2017Proceedings.pdf|Ref3_SPIE 2017 Proceedings]] 
 
* [[Media:Ref5_Avila_etal_IWCLCTapeQAAbstract.pdf|Ref5_Avila_et al_IWCLC Tape QA Abstract]] 
 
* [[Media:Ref6_Avila_etal_WCTIHotTopicAbstract.pdf|Ref6_Avila_etal_WCTI Hot Topic Abstract]] 
 
* [[Media:Ref7_Avila_etal_ANovel UltraLowCostCTImageQualityMeasurementDev.pdf|Ref7_Avila_et al_A Novel Ultra Low Cost CT Image Quality Measurement Dev]]
 
* [[Media:Ref8_Avila_etal_AutomaticEstimationofMeasurementErroronCT Imaging.pdf|Ref8_Avila_et al_Automatic Estimation of Measurement Error on CT Imaging]] 
 
 
 
 
 
* [[Media:QIBA_CT_Vol_LungNoduleAssessmentInCTScreening_2017.07.rev15.pdf|QIBA Lung Nodule Profile]] ''Draft 2017.08.02''
 
:* [[Media:QIBA_CT_Vol_LungNoduleAssessmentInCTScreening_2017.05.15+KOD.docx|Comments on mid-May draft from Kevin]] ''2017.06.06''
 
 
 
'''Status - Public Comment complete'''
 
* [[Media:QIBA_CT_Vol_LungNoduleAssessmentInCTScreening_v5-2-16b.docx|QIBA Profile: CT Lung Nodule Assessment in Screening]] ''Public Comment 2016.06.01 (ended Sept 2016)''
 
:* [[Media:QIBA Small Nodule Profile References - Accuracy.xlsx|Spreadsheet: Small Nodule Profile References_Accuracy]]
 
:* [[Media:QIBA Small Nodule Profile References - Precision.xlsx|Spreadsheet: Small Nodule Profile References_Precision]]
 
 
 
Past
 
:*[[Archive for Lung Nodule Assessment in CT Screening Draft Profiles|Archived Versions]] of Profile-related documents.
 
  
 
==Groundwork Projects==
 
==Groundwork Projects==
Line 79: Line 57:
 
*Dr Mulshine's Presentation Materials from July 2nd adapted from the ATCC Website
 
*Dr Mulshine's Presentation Materials from July 2nd adapted from the ATCC Website
 
**[[Media:ATCC is an independent private nonprofit 7-3-12.pdf|ATCC is an independent, private, nonprofit biological resource center (BRC) and research organization.]]
 
**[[Media:ATCC is an independent private nonprofit 7-3-12.pdf|ATCC is an independent, private, nonprofit biological resource center (BRC) and research organization.]]
*[[Media:Why_QIBA_CT_specifics.pdf|"Why QIBA?" - Specifics associated with CT device and software manufacturers.]]
+
*[[Media:Why QIBA CT specifics.pdf|"Why QIBA?" - Specifics associated with CT device and software manufacturers.]]
  
 
'''2011'''
 
'''2011'''
Line 89: Line 67:
 
'''2010'''
 
'''2010'''
 
*[[Media:Quantification in Imaging-Dr Dirk Colditz-20100823.ppt|Quantification in Imaging-Dr Dirk Colditz]] ''August 23, 2010''
 
*[[Media:Quantification in Imaging-Dr Dirk Colditz-20100823.ppt|Quantification in Imaging-Dr Dirk Colditz]] ''August 23, 2010''
*[[Media: Plan as of 11-8-10.jpg|Project plan]] ''.jpg version as of 11-8-10''
+
*[[Media:Plan as of 11-8-10.jpg|Project plan]] ''.jpg version as of 11-8-10''
  
 
==Reference Articles==
 
==Reference Articles==
Line 111: Line 89:
 
*[[CoreLab Partners, Inc., Round-2]]
 
*[[CoreLab Partners, Inc., Round-2]]
 
*[[David Geffen School of Medicine at UCLA, Department of Radiology,Round-2]]
 
*[[David Geffen School of Medicine at UCLA, Department of Radiology,Round-2]]
 +
 +
'''Round 3'''
 +
*[[Media:Second 3A Statistical and Image Processing Analysis.pdf| Project (F) Second 3A Statistical and Image Processing Analysis (Elucid Bioimaging Inc.)]]
 +
 +
'''Round 4'''
 +
*[[Media:Methodology and Reference Image Set for Volumetric Characterization and Compliance.pdf| Project (Q) Phantoms Methodology and Reference Image Set for Volumetric Characterization and Compliance (Duke University)]]
 +
 +
*[[Media:Phantoms for CT Volumetry of Hepatic and Nodal Metastasis.pdf| Project (S) Phantoms for CT Volumetry of Hepatic and Nodal Metastasis (CUMC)]]
 +
 +
'''Round 5'''
 +
*[[Media:Reference Image Set for Quantitation Conformance of Algorithmic Lesion Characterization.pdf| Project (C) Reference Image Set for Quantitation Conformance of Algorithmic Lesion Characterization (Duke University)]]
 +
 +
'''Round 6'''
 +
*[[Media:Methodology and Reference Image Set for Lesion Characterization in Terms of Texture and Morphology.pdf| Project (S) Methodology and Reference Image Set for Lesion Characterization in Terms of Texture and Morphology (Duke University)]]

Latest revision as of 17:44, 20 October 2022

Co-chairs: Rudresh Jarecha, MBBS, DNB, DMRE; Ehsan Samei, PhD and TBD
RSNA Staff Support: Julie Lisiecki

Meetings

  • Tcons are held periodically. Contact RSNA Staff for details.


Recent Call Summaries:


CT Volumetry BC Call Summaries Archive

Profile Development

Streamlined Profile (also on Profile page)

  • 32 pages including Conformance Checklists


Status - Balloting Streamlined Profile

The Technically Confirmed Profile is on the Profiles page.

Stage 4 Planning

Past and Future

Groundwork Projects

These projects investigate (and resolve) scientific questions underlying QIBA Profile work.

  • VolCT - Group 1A - Analyze Bias/Variance where Ground Truth is Known Deterministically
  • VolCT - Group 1B - Focus on Volume Change Analysis of Pulmonary Nodules in Diagnostic Settings
  • VolCT - Group 1C - Model Sources of Variability from a Systems Engineering Analysis
  • VolCT - Group 3A - Characterize variability due to algorithms (using phantoms / clinical data)
  • VolCT - Group 3B - Characterize clinical utility/efficacy with respect to clinical endpoints
  • VolCT - Colorado Group - Quantifying variability in measurement of pulmonary nodule

Reference Materials

2012

2011

2010

Reference Articles

  • Are we ready? A time for measurement of physiological parameters of the lung using multidetector row CT scans. Hatabu H. Acad Radiol. 2009 Mar; 16(3):249. Academic Radiology
  • Radiology 2007 - Coronary Calcium Scoring - This paper by Dr. McCollough et al is may be seen to be analaogous to our work in that it addresses similar issues (e.g. achieving "standard" noise levels). It could be thought of as an early draft of a Calcium Scoring profile, including both groundwork and equipment specifications.
  • Helical multidetector row quantitative computed tomography (QCT) precision. Bligh M, Bidaut L, White RA, Murphy WA Jr, Stevens DM, Cody DD. Acad Radiol. 2009 Feb; 16(2):150-9. Academic Radiology
  • Comparison of the accuracy of CT volume calculated by circumscription to prolate ellipsoid volume (bidimensional measurement multiplied by coronal long axis). Rkein AM, Harrigal C, Friedman AC, Persky D, Krupinski E. Acad Radiol. 2009 Feb; 16(2):181-6. Academic Radiology

QIBA Funded Projects

Round 1

Round 2

Round 3

Round 4

Round 5

Round 6